These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21413548)

  • 21. A prospective randomized trial on the role of perioperative celecoxib administration for total knee arthroplasty: improving clinical outcomes.
    Reuben SS; Buvenandran A; Katz B; Kroin JS
    Anesth Analg; 2008 Apr; 106(4):1258-64, table of contents. PubMed ID: 18349203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longer use of COX-2-specific inhibitors compared to nonspecific nonsteroidal antiinflammatory drugs: a longitudinal study of 3639 patients in community practice.
    Wolfe F; Michaud K; Burke TA; Zhao SZ
    J Rheumatol; 2004 Feb; 31(2):355-8. PubMed ID: 14760808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of oral ibuprofen and celecoxib in preventing pain, improving recovery outcomes and patient satisfaction after ambulatory surgery.
    White PF; Tang J; Wender RH; Zhao M; Time M; Zaentz A; Yumul R; Sloninsky A; Naruse R; Kariger R; Webb T; Fermelia DE; Tsushima GK
    Anesth Analg; 2011 Feb; 112(2):323-9. PubMed ID: 21156974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preemptive effect of ketoprofen on postoperative pain following third molar surgery. A prospective, randomized, double-blinded clinical trial.
    Kaczmarzyk T; Wichlinski J; Stypulkowska J; Zaleska M; Woron J
    Int J Oral Maxillofac Surg; 2010 Jul; 39(7):647-52. PubMed ID: 20338728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combining paracetamol with a selective cyclooxygenase-2 inhibitor for acute pain relief after third molar surgery: a randomized, double-blind, placebo-controlled study.
    Haglund B; von Bültzingslöwen I
    Eur J Oral Sci; 2006 Aug; 114(4):293-301. PubMed ID: 16911100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of pre-emptive ibuprofen, paracetamol, and placebo administration in reducing post-operative pain in primary tooth extraction.
    Baygin O; Tuzuner T; Isik B; Kusgoz A; Tanriver M
    Int J Paediatr Dent; 2011 Jul; 21(4):306-13. PubMed ID: 21470320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug testing. Massive trial of Celebrex seeks to settle safety concerns.
    Couzin J
    Science; 2005 Dec; 310(5756):1890-1. PubMed ID: 16373546
    [No Abstract]   [Full Text] [Related]  

  • 28. The safety of the perioperative administration of cyclooxygenase-2 inhibitors for post-surgical pain.
    Reuben SS
    Acta Anaesthesiol Scand; 2005 Mar; 49(3):424; author reply 425. PubMed ID: 15752415
    [No Abstract]   [Full Text] [Related]  

  • 29. Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction.
    Gislason GH; Jacobsen S; Rasmussen JN; Rasmussen S; Buch P; Friberg J; Schramm TK; Abildstrom SZ; Køber L; Madsen M; Torp-Pedersen C
    Circulation; 2006 Jun; 113(25):2906-13. PubMed ID: 16785336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between nonnaproxen NSAIDs, COX-2 inhibitors and hospitalization for acute myocardial infarction among the elderly: a retrospective cohort study.
    Rahme E; Watson DJ; Kong SX; Toubouti Y; LeLorier J
    Pharmacoepidemiol Drug Saf; 2007 May; 16(5):493-503. PubMed ID: 17086567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-dose and multi-dose clindamycin therapy fails to demonstrate efficacy in preventing infectious and inflammatory complications in third molar surgery.
    Kaczmarzyk T; Wichlinski J; Stypulkowska J; Zaleska M; Panas M; Woron J
    Int J Oral Maxillofac Surg; 2007 May; 36(5):417-22. PubMed ID: 17408924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of pre-emptive analgesia on clinical parameters and tissue levels of TNF-α and IL-1β in third molar surgery: a triple-blind, randomized, placebo-controlled study.
    Albuquerque AFM; Fonteles CSR; do Val DR; Chaves HV; Bezerra MM; Pereira KMA; de Barros Silva PG; de Lima BB; Soares ECS; Ribeiro TR; Costa FWG
    Int J Oral Maxillofac Surg; 2017 Dec; 46(12):1615-1625. PubMed ID: 28610818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The burden of acute postoperative pain and the potential role of the COX-2-specific inhibitors.
    Stephens J; Laskin B; Pashos C; Peña B; Wong J
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii40-52. PubMed ID: 14585917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MK-0703 (a cyclooxygenase-2 inhibitor) in acute pain associated with dental surgery: a randomized, double-blind, placebo- and active comparator-controlled dose-ranging study.
    Schwartz JI; Kotey PN; Fricke JR; Gottesdiener K
    Am J Ther; 2007; 14(1):13-9. PubMed ID: 17303970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug.
    Dougados M; Béhier JM; Jolchine I; Calin A; van der Heijde D; Olivieri I; Zeidler H; Herman H
    Arthritis Rheum; 2001 Jan; 44(1):180-5. PubMed ID: 11212158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?
    Geis GS
    Scand J Rheumatol Suppl; 1999; 109():31-7. PubMed ID: 10422544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Celecoxib for the treatment of pain and inflammation: the preclinical and clinical results.
    Tindall E
    J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S13-7. PubMed ID: 10643176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analgesic efficacy of the cyclooxygenase-2-specific inhibitor rofecoxib in post-dental surgery pain: a randomized, controlled trial.
    Morrison BW; Christensen S; Yuan W; Brown J; Amlani S; Seidenberg B
    Clin Ther; 1999 Jun; 21(6):943-53. PubMed ID: 10440619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Selective COX 2 inhibitor rofecoxib. To "defy" the pain].
    MMW Fortschr Med; 2003 Aug; 145(31-32):56-7. PubMed ID: 14524083
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of topical viscous 2% lidocaine jelly as an adjunct during the management of alveolar osteitis.
    Betts NJ; Makowski G; Shen YH; Hersh EV
    J Oral Maxillofac Surg; 1995 Oct; 53(10):1140-4. PubMed ID: 7562165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.